AU2001266689A1 - 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof - Google Patents

4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof

Info

Publication number
AU2001266689A1
AU2001266689A1 AU2001266689A AU6668901A AU2001266689A1 AU 2001266689 A1 AU2001266689 A1 AU 2001266689A1 AU 2001266689 A AU2001266689 A AU 2001266689A AU 6668901 A AU6668901 A AU 6668901A AU 2001266689 A1 AU2001266689 A1 AU 2001266689A1
Authority
AU
Australia
Prior art keywords
oxazin
benzyl
hydroxy
polymorphic forms
polymorphic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266689A
Inventor
Karel M. Jos Brands
Louis S. Crocker
Todd D Nelson
Philip J. Pye
Jonathan D. Rosen
Kai Rossen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2001266689A1 publication Critical patent/AU2001266689A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
AU2001266689A 2000-06-08 2001-06-04 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof Abandoned AU2001266689A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21020400P 2000-06-08 2000-06-08
US21025400P 2000-06-08 2000-06-08
US60210204 2000-06-08
US60210254 2000-06-08
PCT/US2001/018038 WO2001094322A1 (en) 2000-06-08 2001-06-04 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof

Publications (1)

Publication Number Publication Date
AU2001266689A1 true AU2001266689A1 (en) 2001-12-17

Family

ID=26904943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266689A Abandoned AU2001266689A1 (en) 2000-06-08 2001-06-04 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof

Country Status (4)

Country Link
US (1) US6538134B2 (en)
EP (1) EP1292582A1 (en)
AU (1) AU2001266689A1 (en)
WO (1) WO2001094322A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1390355A4 (en) * 2001-02-27 2005-02-23 Teva Pharma New crystal forms of lamotrigine and processes for their preparations
US20050238724A1 (en) * 2002-04-23 2005-10-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
FR2953720B1 (en) 2009-12-11 2012-05-11 Oreal USE OF BENZYLOXY ETHYLAMINE DERIVATIVES AS A CONSERVATIVE,
WO2012146692A1 (en) 2011-04-29 2012-11-01 Sandoz Ag Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant
CN102675240B (en) * 2012-04-13 2015-01-14 浙江海正药业股份有限公司 4-substitute-2-hydroxy morpholine-3-ketone and preparation method thereof
CN110869368B (en) * 2017-07-13 2023-03-28 大正制药株式会社 Process for the preparation of (2S) -2- [ (1H-pyrazol-1-yl) methyl ] -1, 3-oxazinane derivatives
CN110483436B (en) * 2019-09-19 2021-07-16 西安凯立新材料股份有限公司 Method for preparing 4-benzyl-2-hydroxy-morpholine-3-one

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9819890D0 (en) * 1998-09-11 1998-11-04 Merck Sharp & Dohme Chemical synthesis

Also Published As

Publication number Publication date
WO2001094322A1 (en) 2001-12-13
EP1292582A1 (en) 2003-03-19
US20020042510A1 (en) 2002-04-11
US6538134B2 (en) 2003-03-25

Similar Documents

Publication Publication Date Title
AU6419701A (en) Electropancreatography
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001290931A1 (en) Ski-snowboard
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001281921A1 (en) Bdellosomes
AU2001266689A1 (en) 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
AU2001266176A1 (en) Methods
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2001250536A1 (en) Methods
AU2001284173A1 (en) Calycins